OncoSec Medical Inc organizacji Beta
Jaka jest wartość Beta organizacji OncoSec Medical Inc?
Wartość Beta organizacji OncoSec Medical Inc to 0.00
Jaka jest definicja Beta?
BETA wskazuje, czy akcje są bardziej lub mniej zmienne niż rynek jako całość. Beta mniejsza niż 1 wskazuje, że akcje są mniej zmienne niż rynek, a beta więcej niż 1 wskazuje, że akcje są bardziej niestabilne. Zmienność jest mierzona jako fluktuacja ceny wokół średniej.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta firm w Health Care sektor na NASDAQ w porównaniu do OncoSec Medical Inc
Czym się zajmuję organizacja OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Firmy z beta podobne do OncoSec Medical Inc
- Wartość Beta organizacji Vision Marine Technologies to 0.00
- Wartość Beta organizacji Ely Gold Royalties to 0.00
- Wartość Beta organizacji Glacier Lake Resources to 0.00
- Wartość Beta organizacji Magnum Mining and Exploration to 0.00
- Wartość Beta organizacji Africa Opportunity Fund to 0.00
- Wartość Beta organizacji Fulcrum Utility Services to 0.00
- Wartość Beta organizacji OncoSec Medical Inc to 0.00
- Wartość Beta organizacji Gullewa to 0.00
- Wartość Beta organizacji S.A.L. Steel to 0.00
- Wartość Beta organizacji Andina Acquisition III to 0.00
- Wartość Beta organizacji Andina Acquisition III to 0.00
- Wartość Beta organizacji Brilliant Acquisition to 0.00
- Wartość Beta organizacji Indokem to 0.00